Shareholder Lombard Odier Asset Management Usa Boosted Navigators Group (NAVG) Stake; P-A-W Capital Position in Chemocentryx (CCXI) Lowered by $400,000

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

P-A-W Capital Corp decreased its stake in Chemocentryx Inc (CCXI) by 44.44% based on its latest 2018Q4 regulatory filing with the SEC. P-A-W Capital Corp sold 40,000 shares as the company’s stock rose 6.99% with the market. The hedge fund held 50,000 shares of the health care company at the end of 2018Q4, valued at $546,000, down from 90,000 at the end of the previous reported quarter. P-A-W Capital Corp who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $735.43 million market cap company. The stock decreased 1.55% or $0.2 during the last trading session, reaching $12.74. About 46,198 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since May 2, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx

Lombard Odier Asset Management Usa Corp increased its stake in Navigators Group Inc (NAVG) by 50% based on its latest 2018Q4 regulatory filing with the SEC. Lombard Odier Asset Management Usa Corp bought 5,000 shares as the company’s stock rose 0.35% with the market. The institutional investor held 15,000 shares of the finance company at the end of 2018Q4, valued at $1.04M, up from 10,000 at the end of the previous reported quarter. Lombard Odier Asset Management Usa Corp who had been investing in Navigators Group Inc for a number of months, seems to be bullish on the $2.08B market cap company. The stock decreased 0.01% or $0.01 during the last trading session, reaching $69.86. About 27,877 shares traded. The Navigators Group, Inc. (NASDAQ:NAVG) has risen 29.70% since May 2, 2018 and is uptrending. It has outperformed by 25.33% the S&P500. Some Historical NAVG News: 06/04/2018 – Navigators Group Forms Golden Cross: Technicals; 07/05/2018 – Navigators Group 1Q EPS $1.02; 07/05/2018 – Navigators Group 1Q Rev $344.2M; 13/04/2018 – NAVIGATORS GROUP FILES MIXED SECURITIES SHELF; 09/05/2018 – NAVIGATORS GROUP INC NAVG.O : KBW RAISES TO MARKET PERFORM FROM UNDERPERFORM; 10/05/2018 – Navigators Announces Second Quarter 2018 Dividend; 12/04/2018 – City of Chicago: Postsecondary Navigators Begin Work Helping Students Create Postsecondary Plans; 09/04/2018 – AIR FRANCE-KLM AIRF.PA – 20.2 PCT OF COMMERCIAL NAVIGATORS ARE EXPECTED TO BE ON STRIKE ON APRIL 10; 21/04/2018 – DJ Navigators Group Inc, Inst Holders, 1Q 2018 (NAVG); 04/04/2018 Navigators and Protective Insurance Enter into Workers’ Compensation Underwriting Partnership

P-A-W Capital Corp, which manages about $79.74 million US Long portfolio, upped its stake in Eiger Biopharmaceuticals Inc by 185,000 shares to 220,000 shares, valued at $2.24M in 2018Q4, according to the filing.

Investors sentiment decreased to 0.93 in 2018 Q4. Its down 0.05, from 0.98 in 2018Q3. It turned negative, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Moreover, State Common Retirement Fund has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). California State Teachers Retirement System has 35,245 shares for 0% of their portfolio. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta has 37,000 shares. Metropolitan Life Insurance New York has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Barclays Public Ltd Liability holds 0% or 5,866 shares. State Of Wisconsin Invest Board invested in 23,200 shares or 0% of the stock. Matarin Mngmt Ltd Limited Liability Company has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). Cadence Management Limited Com accumulated 0.11% or 103,341 shares. Ameritas Inv Prtn Incorporated reported 2,120 shares stake. 257 are held by Tower Research Capital Limited Liability Co (Trc). Los Angeles Equity Rech has 19,032 shares. Daiwa Group owns 269 shares for 0% of their portfolio. D E Shaw Co accumulated 214,899 shares. Arrowstreet Lp holds 0.01% or 220,004 shares. Sg Americas Securities Limited Liability holds 17,971 shares or 0% of its portfolio.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Nasdaq.com which released: “After-Hours Earnings Report for March 11, 2019 : ADT, COUP, SFIX, DRNA, AVD, PETQ, CCXI, LXFR, MG, OXFD, FRTA, KALA – Nasdaq” on March 11, 2019, also Seekingalpha.com with their article: “ChemoCentryx Looks Like An Attractive Investment – Seeking Alpha” published on November 22, 2017, Seekingalpha.com published: “ChemoCentryx withdraws conditional approval application for avacopan in Europe – Seeking Alpha” on January 24, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Globenewswire.com and their article: “ChemoCentryx Appoints Rita Jain, M.D. to Board of Directors – GlobeNewswire” published on March 28, 2019 as well as Zacks.com‘s news article titled: “ChemoCentryx (CCXI) Reports Q4 Loss, Lags Revenue Estimates – Zacks.com” with publication date: March 11, 2019.

Since November 7, 2018, it had 0 insider buys, and 6 sales for $1.47 million activity. Schall Thomas J. had sold 7,211 shares worth $86,554 on Wednesday, November 7. Shares for $457,747 were sold by KANAYA SUSAN M.

Investors sentiment decreased to 1.13 in 2018 Q4. Its down 0.45, from 1.58 in 2018Q3. It is negative, as 19 investors sold NAVG shares while 51 reduced holdings. 26 funds opened positions while 53 raised stakes. 21.15 million shares or 2.02% more from 20.73 million shares in 2018Q3 were reported. Captrust Financial reported 95 shares stake. Franklin Res has invested 0% in The Navigators Group, Inc. (NASDAQ:NAVG). Arizona State Retirement System invested in 0.03% or 35,769 shares. Barclays Public Limited Co holds 0% or 43,619 shares in its portfolio. Credit Suisse Ag reported 33,150 shares. Amalgamated State Bank holds 0.01% in The Navigators Group, Inc. (NASDAQ:NAVG) or 3,086 shares. Ancora Advsr Lc accumulated 7,006 shares. Ameritas Inv Ptnrs Inc holds 0.01% or 1,783 shares in its portfolio. Advisory holds 229,002 shares. Moreover, Bankshares Of America Corporation De has 0% invested in The Navigators Group, Inc. (NASDAQ:NAVG) for 256,114 shares. Us Fincl Bank De holds 0% of its portfolio in The Navigators Group, Inc. (NASDAQ:NAVG) for 332 shares. Invest Counselors Of Maryland Limited reported 1.15% of its portfolio in The Navigators Group, Inc. (NASDAQ:NAVG). Regions Fincl Corporation reported 0% of its portfolio in The Navigators Group, Inc. (NASDAQ:NAVG). Martingale Asset Mgmt Lp reported 0.08% in The Navigators Group, Inc. (NASDAQ:NAVG). Gabelli & Advisers reported 0.52% of its portfolio in The Navigators Group, Inc. (NASDAQ:NAVG).

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *